학술논문
Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation
Document Type
Article
Author
Source
In: Pathobiology . (Pathobiology, 14 August 2023, 91(2):108-113)
Subject
Language
English
ISSN
14230291
10152008
10152008